American Cancer Society 2020 Reports Largest One-year Drop in Cancer Mortality
According to an annual statistics report from the American Cancer Society the death rate from cancer in the US declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop ever recorded.
The decline in deaths from lung cancer drove the record drop. Deaths fell from about 3% per year from 2008 – 2013 to 5% from 2013 – 2017 in men and from 2% to almost 4% in women. However, lung cancer is still the leading cause of cancer death.
The report also credits advancements in treatment as major factor in decrease of lung cancer death rate.
“The accelerated drops in lung cancer mortality as well as in melanoma that we’re seeing are likely due at least in part to advances in cancer treatment over the past decade, such as immunotherapy,” said William G. Cance, MD, chief medical and scientific officer for the American Cancer Society, in a statement. “They are a profound reminder of how rapidly this area of research is expanding, and now leading to real hope for cancer patients.”
This report gives us hope, it also shows that the support of our donors is truly helping the medical community develop advances in treatment that are changing the way we treat lung cancer. However, since lung cancer remains the leading cause of cancer deaths, it also illustrates how important it is to continue support promising clinical trials
Consider donating today and join us in our fight to help cure lung cancer.
Download the ACS cancer facts and statics report here: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2020/cancer-facts-and-figures-2020.pdf
The 3rd Annual Gala of the Joan DeCotis Foundation
Remarkable Success for Third Annual Joan DeCotis Foundation Fundraising Gala
On August 1, 2019, the Joan DeCotis Foundation hosted its third fundraising gala at The Dunes Club in Narragansett, Rhode Island. During this special evening under the stars, over 300 guests enjoyed dinner and silent and live auctions, all with a common goal: to raise funds for lung cancer support and research. Thanks to the incredible generosity of attendees and supporters, this year’s gala raised over $110,000.
“Our gala and auction provide a wonderful opportunity for lung cancer patients and survivors, their caregivers, healthcare professionals, and members of the community to see first-hand how important philanthropic support is in the research and development of clinical trials”, said Kristen Decotis-Liguori, Joan DeCotis Foundation Board Member. “We are thrilled with the outpouring of support as these trials continue to offer some of the best treatment hope for those with lung cancer.” This is the Foundation’s third significant fundraiser held to fund innovative clinical treatments for lung cancer patients and to shine a light on this devastating disease.
Since 2016, the Joan DeCotis Foundation has partnered with Brown University Oncology Research Group (BrUOG), one of the leading cancer research groups in the county, whose mission is to improve cancer care through the implementation of innovative, multidisciplinary cancer clinical trials. The Foundation was honored to present a check to BrUOG on November 7, 2019, to help continue to drive these important advances in the treatment of lung cancer.
The Foundation wishes to extend its sincere gratitude to the many sponsors who helped make the event a remarkable milestone, especially premium sponsor Anchor Subaru, and the following platinum sponsors: ASSA ABLOY, CORE Cycle.Fitness.Lagree, Croton Stokes Wilson Holden, DeCotis Specialty Insurance, Jones Kelleher LLP, Koda Creative Group, the Liguori family, Mark McGovern, Rhode Island Monthly, and the Skeffington family.
